Learn How To Win On Wall Street With Paul Mampilly

Paul Mampilly is an experienced hedge fund manager and a successful investor. He relies on intensive research and analysis to identify stocks that outperform investor benchmarks. He is the founder of Capuchin Consulting, an investment advisory firm, which he established in 2013. He also runs multiple financial journals distributed by Banyan Hill Publishing. He has also worked for numerous organizations such as Stansberry Research, Agora Financial, Palm Beach Research and Kinetics Asset Management.

Paul Mampilly graduated from Montclair State University with a degree in finance. He then proceeded to Fordham Graduate School of Business. He launched his Wall Street career at Bankers Trust in 1991. He then moved on to work for prominent investment companies such as Deutsche Bank and ING. From 2006, he was involved in the management of a hedge fund for Kinetics Asset Management.

He grew the fund from $6 billion to $25 billion, winning the recognition of Barrons, a premier financial magazine in the US. In like manner, he took part in a Templeton Foundation investment contest where he rapidly grew a $50 million kitty to over $88 million within a year during the 2008 financial crunch.

Paul focuses on educating and advising the masses on ways to benefit from Wall Street. He achieves this with insightful and well researched financial journals and trading services. His research is affordable and highly targeted.

He is the founder of several subscription journals. These include Profits Unlimited, an extremely popular publication guiding low-risk investments targeting emergent trends such as the internet of things and Extreme Fortunes, a guide to the most lucrative investments in the industry. He also runs True Momentum, a medium-risk, high-yield investment advisory journal. Additionally, he posts a weekly column on Winning Investor Daily.

Paul has authored numerous financial articles and appeared on various channels such as CNBC and Bloomberg. He has made wildly successful bets with the stocks of companies such as Sarepta Therapeutics, Netflix, Stratasys, Exact Sciences and Whole Foods among many others. His newsletters have rapidly grown to become the go-to source of expert investment advisory for segments such as technology, electric vehicles and precision medicine among others. Learn more:


Leave a Reply

Your email address will not be published. Required fields are marked *


Hi, guest!